SOTIO a.s.
BioTech/Drugs - Boston, MA, US
SOTIO a.s. Details
SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO's robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.
Website:
sotio.com
Employees:
250 - 499
HQ:
N/A
Location:
Boston, MA, US
Revenue:
5 - 10 Million
SOTIO a.s. Technologies
Email Providers
Outlook
Load Balancers
Nginx
Advertising Networks
Twitter Advertising
Other
Mobile Friendly